Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued

Growth Metrics

Others

Avidity Biosciences, Inc. (RNA) Non-cash Items (2020 - 2021)

Avidity Biosciences' Non-cash Items history spans 2 years, with the latest figure at $1.9 million for Q4 2021.

For Q4 2021, Non-cash Items fell 97.1% year-over-year to $1.9 million; the TTM value through Dec 2021 reached $1.9 million, down 97.1%, while the annual FY2021 figure was $1.9 million, 97.1% down from the prior year.
Non-cash Items reached $1.9 million in Q4 2021 per RNA's latest filing, down from $65.1 million in the prior quarter.
In the past five years, Non-cash Items ranged from a high of $65.1 million in Q4 2020 to a low of $1.9 million in Q4 2021.